Intelligence Platform
Patents
Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8247225
DNA promoters and anthrax vaccines
granted patentUS 8242160
Inhibitors of ubiquitin E1
granted patentUS 8227443
Silencing of CSN5 gene expression using interfering RNA
granted patentUS 8227417
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
granted patentUS 8217158
Immunotoxin fusion proteins and means for expression thereof
granted patentUS 8211422
Chimeric receptor genes and cells transformed therewith
granted patentUS 8202551
Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical appl
granted patentUS 8202520
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
granted patentUS 8198402
Smoothened polypeptides and methods of use
granted patentUS 8188055
Inactivators of O6-alkylguanine-DNA alkyltransferase
granted patentUS 8178508
Methods of stimulating an immune response against prostate specific antigen
granted patentUS 8173123
Methods of treating colitis involving IL-13 and NK-T cells
granted patentUS 8153781
Dendrimer conjugates of agonists and antagonists of the GPCR superfamily
granted patentUS 8147840
Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stab
granted patentUS 8125225
Transmit profile control in MRI
granted patentUS 8110192
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies wit
granted patentUS 8110352
Method of diagnosing and treating cancer using B-catenin splice variants
granted patentUS 8110681
Compounds for the treatment of spinal muscular atrophy and other uses
granted patentUS 8093343
Nitric oxide-releasing diazeniumdiolated compounds
granted patentUS 8088729
Anti-viral griffithsin compounds, compositions and methods of use
granted patentUS 8088787
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted patentUS 8075900
Melanoma associated peptide analogues and vaccines against melanoma
granted patentUS 8071746
Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID
granted patentUS 8048427
Subgenomic replicons of the flavivirus dengue
granted